FDA Issues Over 100 Warnings in Ad Crackdown

16 Sep 2025 //

RAPS

GSK et al file appeal to Delaware Zantac order

12 Jun 2024 //

PHARMAPHORUM

Chicago jury rules for GSK, Boehringer in key Zantac trial

24 May 2024 //

FIERCE PHARMA

Watchdog sues FDA for stalling on Parkinson`s drug warnings

01 May 2019 //

FIERCE PHARMA

New Zealand Adopts Major Revision to Clinical Trial Rules

13 Nov 2018 //

RAPS

FDA Experts May Reconsider Diabetes Drug Safety Rules

26 Oct 2018 //

FORBES

Challenge to Original FDA Approved Warning Preempted

27 Nov 2017 //

DRUGANDDEVICE

Buscopan withdrawn from the market has substitutes

10 Aug 2017 //

ANVISA

Five pharmas Fall Foul of ABPI Code of Practice

15 Dec 2016 //

PHARMATIMES

Eleven medicines leap towards EU approval

19 Sep 2016 //

PHARMATIMES

Diabetes rivalries get more complicated with new FDA warning on J&J`s Invokana

15 Sep 2015 //

FIERCE PHARMA

FDA warns of severe joint pain risk with DPP-4 diabetes drugs

29 Aug 2015 //

REUTERS

In Case You Missed It ,We Did! Prometheus Takes Action Against FDA Over Generic LOTRONEX Approval...

25 Jun 2015 //

FDA LAW BLOG

G.D. Searle LLC v. Lupin Pharmaceuticals, Inc. (Fed. Cir. 2015)

24 Jun 2015 //

PATENT DOCS

Top Class I drug recallers

17 Jun 2015 //

FIERCE PHARMA MANUFACTURING

FDA rejects approval of the “Female Viagra” for the third time in a row

04 Jun 2015 //

DRUG REGULATIONS

Certain Diabetes Drug may Cause Adverse Reaction, Warns FDA

20 May 2015 //

BIOSPECTRUM ASIA

Should FDA Penalize Drug Makers Over Diabetes Drug Ads?

01 Apr 2015 //

PHARMALOT

Antitrust Lawsuit Over Aggrenox Prices Can Go On, Judge Rules

25 Mar 2015 //

REUTERS

Firms Team Up To Sustain Natural Pilocarpine

17 Mar 2015 //

Boehringer Ingelheim Pharma GMBH & Co receives US FDA Warning Letter

08 Oct 2013 //

FDA

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass